Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA

Abstract excerpt

Serological testing of large representative populations for antibodies to SARS-CoV-2 is needed to estimate seroprevalence, transmission dynamics, and the duration of antibody responses from natural infection and vaccination. In this study, a high-throughput SARS-CoV-2 multiplex microsphere immunoassay (MMIA) was developed for the receptor binding domain (RBD) and nucleocapsid (N) that was more sensitive than...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biosensors and Analytical Detection
• Share to SARS-CoV-2 and COVID-19 Research
• Share to SARS-CoV-2 detection and testing